Biopharma Co. Catalent Cuts Deal With Activist Elliott
Pharmaceutical company Catalent said Tuesday that it was shaking up its board and undertaking a strategic review in connection with an agreement with activist investor Elliott Investment Management....To view the full article, register now.
Already a subscriber? Click here to view full article